NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/22/2024
Back to search
Official data from USPTO
LINCTOBC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LINCTOBC
ST13
US500000079332438Class
9, 42, 44
Filing
79332438
Registration
7220365
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
11/22/2024
Trademark type
Word
Nice classes
9, 42, 44
Filing date
11/17/2021
Registration date
11/21/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/21/2023
Last transaction
11/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
YOO, JEANE
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Representatives
Cathleen E. Stadecker Downs Rachlin Martin PLLC
Technical classification
Nice Classes
Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Scientific and research apparatus and instruments in the field of healthscientific apparatus and instruments for measuring relative DNARNA and protein and parts and fittings thereforprisms for scientific and medical research purposes; Recorded software for diagnosing the risk of developing breast cancer; Downloadable computer application software for mobile phones and handheld computers for diagnosing the risk of developing breast cancer; Downloadable computer software for diagnosing the risk of developing breast cancer and downloadable computer application software for mobile devices for diagnosing the risk of developing breast cancer; Downloadable computer software platforms for diagnosing the risk of developing breast cancer and downloadable mobile application software for diagnosing the risk of developing breast cancer; All of the aforesaid goods dedicated to the diagnosisprognosis and management of breast cancer therapy
Class 42
Scientific research services for medical purposes in the field of breast cancer therapy; Medical research; Designdevelopmentmaintenance and updating of computer software; Development of computer platforms; Computer system design; Computer programming; Electronic data storage; Computer software consultancy; Software as a service (SaaS) services featuring software for diagnosing the risk of developing breast cancer; Platform as a service (PaaS) featuring computer software platforms for diagnosing the risk of developing breast cancer; All of the aforesaid goods dedicated to the diagnosisprognosis and management of breast cancer therapy
Class 44
Health servicesoncologic health care; Medical services; Therapeutic servicesradiotherapeutic agent therapyimmunotherapeutic agent therapychemotherapeutic agent therapy services and surgery; Medical assistance; Medical clinic services and medical analysis services provided by medical laboratories for diagnostic and therapeutic treatment purposes; Advice regarding health; Telemedicine services; All of the aforesaid goods dedicated to the diagnosisprognosis and management of breast cancer therapy
Publications
History of USPTO decisions and trademark events.
35 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/26/2024
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
02/22/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
02/22/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/21/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/05/2023
PUBO
PUBLISHED FOR OPPOSITION
09/05/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/16/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/16/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/16/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/01/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/25/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/05/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/26/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/26/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/26/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/19/2023
GNFR
FINAL REFUSAL E-MAILED
04/19/2023
CNFR
FINAL REFUSAL WRITTEN
04/19/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/30/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/30/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/30/2023
RFNT
REFUSAL PROCESSED BY IB
11/08/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/20/2022
RFRR
REFUSAL PROCESSED BY MPU
10/20/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/27/2022
CNRT
NON-FINAL ACTION WRITTEN
08/26/2022
DOCK
ASSIGNED TO EXAMINER
08/22/2022
MAFR
APPLICATION FILING RECEIPT MAILED
02/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/04/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/03/2022
Continuous trademark protection
Get notified about every new filing that threatens LINCTOBC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.